According to the Union health ministry’s dashboard, India on Wednesday registered 83,347 fresh cases and 1,085 deaths due to the novel coronavirus (Covid-19) disease, which pushed the country’s tally and death toll to 5,646,010 and 90,020 respectively. The active cases have climbed to 968,377 whereas over 4.5 million have recovered so far. This is the fifth consecutive day that single-day recoveries exceeded the cases logged.

Maharashtra, which continues to be one of the worst-hit states in India, logged 21,029 Covid-19 cases which pushed the tally to over 1.2 million. The state’s death toll is nearing 34,000 while active cases amount to 21.63% of the total cases. An internal projection of the state health department said that the tally of fresh cases is likely to go up further.

In Delhi, nearly 10,20,00 people have recovered and 40 have died under home isolation, data from the directorate general of health (DGHS) services showed. On Wednesday, the 17,834 patients were under home isolation, according to the health bulletin.

Meanwhile, the United States-based Johnson & Johnson on Wednesday said that it has entered the third phase of its Covid-19 vaccine clinical trial. A total of 60,000 volunteers across over 200 sites in the US and around the world will be enrolled which will make Johnson and Johnson the tenth maker globally to conduct a Phase 3 trial against Covid-19.